MedDay's Series B Round

MedDay raised a round of funding on April 08, 2016.

MedDay is a privately held biotechnology company developing new drugs targeting brain metabolism to treat diseases of the nervous system. The Company's most advanced pipeline candidate is MD1003 for t…

Articles about MedDay's Series B Round: